Company · CIK 0001635088 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Roivant Sciences Ltd. · ROIV
Insider activity reported against this company. All insider holders · Files at: AXON, UROV, MYOV, ABUS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2026 FForm 4 → | Sep 22, 9:00 pm EDT | Jennifer HumesChief Accounting Officer | 3,880 | $39.77 | $154,308 | 106,419 | — | |
| Sep 20, 2026 FForm 4 → | Sep 22, 6:26 pm EDT | Richard PulikCFO | 2,129 | $39.77 | $84,670 | 269,681 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 9:00 pm EDT | Keith S ManchesterDirector | 5,054 | — | — | 1,753,457 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 7:12 pm EDT | Daniel Allen GoldDirector | 5,054 | — | — | 8,965,815 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 7:06 pm EDT | Ilan OrenDirector | 5,054 | — | — | 123,680 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 7:01 pm EDT | James C MomtazeeDirector | 5,054 | — | — | 111,959 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 6:57 pm EDT | Meghan FitzgeraldDirector | 5,054 | — | — | 41,162 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 6:56 pm EDT | Melissa B, EpperlyDirector | 5,054 | — | — | 14,954 | — | |
| Sep 15, 2026 SForm 4 → | Sep 17, 6:43 pm EDT | Melissa B, EpperlyDirector | 4,938 | $39.74 | $196,230 | 9,900 | −33.3% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 17, 6:42 pm EDT | Meghan FitzgeraldDirector | 5,112 | $39.74 | $203,152 | 36,108 | −12.4% | 10b5-1 |
| Sep 10, 2026 FForm 4 → | Sep 14, 9:00 pm EDT | Daniel Allen GoldDirector | 5,133 | $40.94 | $210,145 | 8,960,761 | — | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:42 pm EDT | Ilan OrenDirector | 2,378 | $40.94 | $97,355 | 118,626 | — | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:34 pm EDT | Melissa B, EpperlyDirector | 2,179 | $40.94 | $89,208 | 14,838 | — | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:29 pm EDT | Meghan FitzgeraldDirector | 1,743 | $40.94 | $71,358 | 41,220 | — | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:25 pm EDT | James C MomtazeeDirector | 2,905 | $40.94 | $118,931 | 106,905 | — | |
| Sep 8, 2026 SForm 4 → | Sep 10, 9:00 pm EDT | Meghan FitzgeraldDirector | 20,000 | $39.90 | $798,000 | 42,963 | −31.8% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 10, 9:00 pm EDT | Meghan FitzgeraldDirector | 20,000 | $8.80 | $176,000 | 62,963 | — | 10b5-1 |
| Aug 28, 2026 SForm 4 → | Sep 1, 9:00 pm EDT | Eric VenkerPresident & Immunovant CEO | 200,000 | $35.77 | $7,153,393 | 1,599,154 | −11.1% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 9:00 pm EDT | Eric VenkerPresident & Immunovant CEO | 200,000 | $3.85 | $770,000 | 1,799,154 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 AForm 4 → | Sep 18, 9:00 pm EDT | Keith S ManchesterDirector | 10,531 | — | — | 10,531 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 7:12 pm EDT | Daniel Allen GoldDirector | 10,531 | — | — | 10,531 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 7:06 pm EDT | Ilan OrenDirector | 10,531 | — | — | 10,531 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 7:01 pm EDT | James C MomtazeeDirector | 10,531 | — | — | 10,531 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 6:57 pm EDT | Meghan FitzgeraldDirector | 10,531 | — | — | 10,531 | — | |
| Sep 16, 2026 AForm 4 → | Sep 18, 6:56 pm EDT | Melissa B, EpperlyDirector | 10,531 | — | — | 10,531 | — | |
| Sep 8, 2026 MForm 4 → | Sep 10, 9:00 pm EDT | Meghan FitzgeraldDirector | 20,000 | — | — | 18,578 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 9:00 pm EDT | Eric VenkerPresident & Immunovant CEO | 200,000 | — | — | 3,844,834 | — | 10b5-1 |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.